Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Routledge

Showing results (191-200 of 205) with videos related to

Pageof 21
Sort By:
The International Journal of Pharmacy Practice|November 9, 2010
Abolition of prescription charges in Wales: the impact on medicines use in those who used to paySam Groves, David Cohen, M Fasihul Alam, et al.
BMJ (Clinical Research Ed.)|February 10, 2007
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trialI A Campbell, D P Bentley, R J Prescott, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 14, 2017
Does the Use of Volumetric Modulated Arc Therapy Reduce Gastrointestinal Symptoms after Pelvic Radiotherapy?K L White, E Varrassi, J A Routledge, et al.
The Journal of Laryngology and Otology|February 13, 2013
Value of the Hospital Anxiety and Depression Scale in the follow up of head and neck cancer patientsL A Joseph, J A Routledge, M P Burns, et al.
QJM : Monthly Journal of the Association of Physicians|December 1, 1996
Changing patterns of self-poisoning in a UK health districtM C Bialas, P G Reid, P Beck, et al.
British Journal of Clinical Pharmacology|March 24, 2022
Changes in suspected adverse drug reaction reporting via the yellow card scheme in Wales following the introduction of a National Reporting IndicatorPaul N Deslandes, Robert Bracchi, Karen Jones, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 29, 2012
Prospective analysis of patient-reported late toxicity following pelvic radiotherapy for gynaecological cancerLisa H Barraclough, Jacqueline A Routledge, Damian J J Farnell, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 18, 2010
Comparison of patient-reported late treatment toxicity (LENT-SOMA) with quality of life (EORTC QLQ-C30 and QLQ-H&N35) assessment after head and neck radiotherapyKean Fatt Ho, Damien J J Farnell, Jacqueline A Routledge, et al.
British Journal of Clinical Pharmacology|November 1, 1987
Determinants of free theophylline clearance in asthmaP E Williams, Y A Alwazir, M Littley, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2009
Developing a CTCAEs patient questionnaire for late toxicity after head and neck radiotherapyK F Ho, D J J Farnell, J A Routledge, et al.
Pageof 21

Showing results (191-200 of 205) with videos related to

Sort By:
Pageof 21
The International Journal of Pharmacy Practice|November 9, 2010
Abolition of prescription charges in Wales: the impact on medicines use in those who used to paySam Groves, David Cohen, M Fasihul Alam, et al.
BMJ (Clinical Research Ed.)|February 10, 2007
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trialI A Campbell, D P Bentley, R J Prescott, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 14, 2017
Does the Use of Volumetric Modulated Arc Therapy Reduce Gastrointestinal Symptoms after Pelvic Radiotherapy?K L White, E Varrassi, J A Routledge, et al.
The Journal of Laryngology and Otology|February 13, 2013
Value of the Hospital Anxiety and Depression Scale in the follow up of head and neck cancer patientsL A Joseph, J A Routledge, M P Burns, et al.
QJM : Monthly Journal of the Association of Physicians|December 1, 1996
Changing patterns of self-poisoning in a UK health districtM C Bialas, P G Reid, P Beck, et al.
British Journal of Clinical Pharmacology|March 24, 2022
Changes in suspected adverse drug reaction reporting via the yellow card scheme in Wales following the introduction of a National Reporting IndicatorPaul N Deslandes, Robert Bracchi, Karen Jones, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 29, 2012
Prospective analysis of patient-reported late toxicity following pelvic radiotherapy for gynaecological cancerLisa H Barraclough, Jacqueline A Routledge, Damian J J Farnell, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 18, 2010
Comparison of patient-reported late treatment toxicity (LENT-SOMA) with quality of life (EORTC QLQ-C30 and QLQ-H&N35) assessment after head and neck radiotherapyKean Fatt Ho, Damien J J Farnell, Jacqueline A Routledge, et al.
British Journal of Clinical Pharmacology|November 1, 1987
Determinants of free theophylline clearance in asthmaP E Williams, Y A Alwazir, M Littley, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2009
Developing a CTCAEs patient questionnaire for late toxicity after head and neck radiotherapyK F Ho, D J J Farnell, J A Routledge, et al.
Pageof 21